Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2015

Erratum for the Research Article: "Integration of Hedgehog and mutant FLT3 signaling in myeloid leukemia" by Y. Lim, L. Gondek, L. Li, Q. Wang, H. Ma, E. Chang, D. L. Huso, S. Foerster, L. Marchionni, K. McGovern, D. N. Watkins, C. D. Peacock, M. Levis, B. Sci Transl Med. 2015;7(295):295er6.

Srivastava A, Chopra S, Pham A, Sooriakumaran P, Durand M, Chughtai B, et al. Corrigendum re: "effect of a risk-stratified grade of nerve-sparing technique on early return of continence after robot-assisted laparoscopic radical prostatectomy" [Eur Urol 2013;63:438-44]. Eur Urol. 2015;68(4):744.

Millard AD, Westblade LF, LiPuma JJ, Vavikolanu K, Read TD, Pallen MJ, et al. Draft Genome Sequence of the Pandoraea apista LMG 16407 Type Strain. Genome Announc. 2015;3(6).

Isella C, Terrasi A, Bellomo SE, Petti C, Galatola G, Muratore A, et al. Stromal contribution to the colorectal cancer transcriptome. Nat Genet. 2015;47(4):312-9.

Jerris RC, Williams SR, MacDonald HJ, Ingebrigtsen DR, Westblade LF, Rogers BB. Testing implications of varying targets for Bordetella pertussis: comparison of the FilmArray Respiratory Panel and the Focus B. pertussis PCR assay. J Clin Pathol. 2015;68(5):394-6.

Llado V, Nakanishi Y, Duran A, Reina-Campos M, Shelton PM, Linares JF, et al. Repression of Intestinal Stem Cell Function and Tumorigenesis through Direct Phosphorylation of β-Catenin and Yap by PKCζ. Cell Rep. 2015;10(5):740-754.

Mathieu R, Lucca I, Mbeutcha A, Seitz C, Karakiewicz P, Sun M, et al. [Not Available]. Prog Urol. 2015;25(13):741-2.

Rodrigues LU, Rider L, Nieto C, Romero L, Karimpour-Fard A, Loda M, et al. Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer. Cancer Res. 2015;75(6):1021-34.

Margetis K, Rajappa P, Cope W, Pisapia D, Souweidane MM. Endoscopic diagnosis of an MRI-occult, low-grade glioma with ependymal dissemination. J Neurosurg Pediatr. 2015;16(4):377-82.

Chen EJ, Sowalsky AG, Gao S, Cai C, Voznesensky O, Schaefer R, et al. Abiraterone treatment in castration-resistant prostate cancer selects for progesterone responsive mutant androgen receptors. Clin Cancer Res. 2015;21(6):1273-80.